Fulgent Genetics, Inc. — Director's Dealing 2022

Dec 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2022-11-30

Reporting Person: Xie Jian (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-30	Common Stock	S	685	$34.3932	Disposed	430074	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	220816	Indirect

Footnotes

F1: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019.

F2: The shares were sold in multiple transactions at prices ranging from $34.0900 to $35.2750, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.